J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Κατάταξη σε μετοχές
#3897
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Τιμή μετοχής
$26.58
Τελευταίος συγχρονισμός: 2026-07-23
Κεφαλαιοποίηση
$4.24B
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
38.40%
Χώρα
IN
Εμπόριο J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Κατηγορία
Healthcare
Δείκτης P/B για J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Δείκτης P/B στις October 2026 TTM: 9.27
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της J. B. Chemicals & Pharmaceuticals Limited, ο τρέχων δείκτης P/B (TTM) είναι 9.27. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 8.99.
Ιστορικό P/B για την J. B. Chemicals & Pharmaceuticals Limited από 2005 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 9.27 | 29.34% |
| 2025 | 7.17 | -20.26% |
| 2024 | 8.99 | 45.87% |
| 2023 | 6.16 | 7.98% |
| 2022 | 5.71 | 6.43% |
| 2021 | 5.36 | 91.96% |
| 2020 | 2.79 | 36.00% |
| 2019 | 2.05 | 12.86% |
| 2018 | 1.82 | -15.48% |
| 2017 | 2.15 | 11.29% |
| 2016 | 1.93 | 13.81% |
| 2015 | 1.70 | 63.33% |
| 2014 | 1.04 | 64.51% |
| 2013 | 0.63 | 18.87% |
| 2012 | 0.53 | -67.05% |
| 2011 | 1.62 | 53.39% |
| 2010 | 1.05 | 60.86% |
| 2009 | 0.65 | -29.39% |
| 2008 | 0.93 | -41.37% |
| 2007 | 1.58 | -43.38% |
| 2006 | 2.79 | 19.52% |
| 2005 | 2.34 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.64% |
IN
|
